We are proud to be part of the EASYGEN consortium
"Decentralized, Automated CAR-T Manufacturing Arrives at the Bedside"
EASYGEN is a project in collaboration with various stakeholders to transform the traditional, centralized, and weeks-long CAR-T cell manufacturing process by moving it to the point of care with a fully automated 24-hour system-cutting costs significantly and expanding timely access to this life-saving therapy for more patients.
EASYGEN is designed to address future challenges in CAR-T therapy by automating manual processes and decentralizing production, removing the capacity limits and logistical hurdles that currently slow down treatment. Its modular, point-of-care system integrates smoothly into existing hospital workflows, easing the burden on clinical staff and helping sustain a resilient healthcare workforce.
By sharply reducing vein-to-vein time and cutting costs by half, EASYGEN will set the stage for scalable, equitable access to life-saving cell therapies.
PRO-LIANCE EXPERTS
It is our task to ensure regulatory compliance of the device, design the initial clinical trials, and actively broaden the regulatory framework for advanced therapeutic medicinal products (ATMPs) in the EU.
Our Partners
Industry & hospitals
Fresenius Group (Coordinator)
Fresenius Kabi
Fenwal, Inc., a Fresenius Kabi Company,
Helios Kliniken GmbH Berlin-Buch,
Quirónsalud,
Philips,
TQ Therapeutics,
Cellix Ltd,
Charles River Laboratories, and
ARTTIC Innovation
Academic/clinical & non-profit
Fraunhofer IZI
Fraunhofer IESE,
Bar-Ilan University,
DTU – Technical University of Denmark,
University of Navarra,
University of Glasgow,
The EBMT, and
Frankfurt School of Finance & Management
Curious to find out more about the project? Check for regular updates!
This project has received funding from the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101194710. The JU receives support from the European Union’s Horizon Europe research and innovation program and EFPIA. – Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.